💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Fiat Chrysler says it did not know about Marchionne's illness

Published 07/26/2018, 02:17 PM
© Reuters. FILE PHOTO: Formula One - F1 - Italian Grand Prix 2017
FCHI
-

ZURICH (Reuters) - Fiat Chrysler (MI:FCHI) said it knew nothing about the medical condition of Sergio Marchionne after a Swiss hospital said on Thursday it had been treating the deceased chief executive for more than a year.

"Due to medical privacy, the company had no knowledge of the facts relating to Mr. Marchionne's health," a Fiat Chrysler spokesman said.

Questions have been raised about how long Marchionne, who died on Wednesday, was ill and how much the company knew before it made the situation public.

Marchionne rescued Fiat and Chrysler from bankruptcy after taking the wheel of the Italian carmaker in 2004 and he multiplied Fiat's value 11 times through 14 years of canny dealmaking. He was due to step down at FCA in April next year.

"The company was made aware that Mr. Marchionne had undergone shoulder surgery and released a statement about this," the spokesperson said.

"On Friday July 20, the Company was made aware with no detail by Mr. Marchionne's family of the serious deterioration in Mr. Marchionne's condition and that as a result he would be unable to return to work. The Company promptly took and announced the appropriate action the following day."

The announcement of the death of Marchionne, 66, one of the

auto industry's most tenacious and respected CEOs, drew tributes

from rivals and tears from his closest colleagues on Wednesday.

University Hospital Zurich said earlier on Thursday Marchionne had been having treatment for a serious illness for more than a year before his death.

Marchionne had fallen gravely ill after what the company had

described as shoulder surgery at a Zurich hospital. He was replaced as chief executive last weekend after Fiat Chrysler (FCA) said his condition had worsened.

"Mr. Sergio Marchionne was a patient at USZ. Due to serious illness, he had been the recipient of recurring treatment for more than a year," the hospital said in a statement.

"Although all the options offered by cutting-edge medicine were utilized, Mr. Marchionne unfortunately passed away."

© Reuters. FILE PHOTO: Formula One - F1 - Italian Grand Prix 2017

University Hospital Zurich declined to comment on Marchionne's illness, but said it deeply regretted his death and expressed its condolences to his family.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.